Aptose Biosciences Market Cap

Aptose Biosciences has a market cap or net worth of CAD 5.59 million as of March 6, 2026. Its market cap has decreased by -68.68% in one year.

Market Cap

5.59M

Enterprise Value

31.22M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

2.19

Market Cap Chart

Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 5.59M, a decrease of -88.18%. That is a compound annual growth rate of -6.50%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	5.59M	3.30%
Dec 31, 2025	5.41M	-72.33%
Dec 31, 2024	19.56M	-26.49%
Dec 29, 2023	26.61M	-63.04%
Dec 30, 2022	71.99M	-53.23%
Dec 31, 2021	153.93M	-69.01%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MYND Life Sciences	5.22M
Quest PharmaTech	5.92M
Kane Biotech	6.36M
Cytophage Technologies	6.43M
BioVaxys Technology	4.63M
COSCIENS Biopharma	6.72M
Restart Life Sciences	7.11M
XORTX Therapeutics	4.18M

Market Cap Rankings